Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

CSPC Pharmaceutical Group (1093N) AI Stock Analysis

MX:1093N

CSPC Pharmaceutical Group

(BMV:1093N)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Very low leverageAn exceptionally conservative balance sheet gives CSPC substantial financial flexibility to fund research, product development, and commercialization without depending heavily on borrowing. Low leverage also reduces interest burden and improves resilience if operating conditions weaken over the next several quarters.
Negative Factors
Soft recent revenue growthRecent top-line weakness suggests that portfolio demand and commercial expansion have not yet returned to a stronger growth trajectory. Low-single-digit growth can limit operating leverage, reduce resources available for reinvestment, and make future earnings increasingly dependent on successful product launches.

CSPC Pharmaceutical Group (1093N) vs. SPDR S&P 500 ETF (SPY)

-10%-5%0%5%10%15%20%MX:1093N+2.16%SPY+12.53%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
MXN 12.66B
Dividend Yield
3.79%
Average Volume (3M)
―
Price to Earnings (P/E)
10.6
Beta (1Y)
0.00
Revenue Growth
12.98%
EPS Growth
80.98%
Country
Mexico
Employees
18,626
Sector
Healthcare
Sector Strength
51
Industry
Drug Manufacturers - General

CSPC Pharmaceutical Group Business Overview & Revenue Model

Company Description

CSPC Pharmaceutical Group Limited, primarily an investment holding entity, is dedicated to the development, production, and distribution of pharmaceutical goods. Its operations span the globe, with a significant presence in the People's Republic of C...

CSPC Pharmaceutical Group Peers Comparison

Overall Rating

Financial Indicators

MX:1093N against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

0%1%1%2%2%MX:1093NDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
MX:1093N and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
MX:1093NCSPC Pharmaceutical Group 16.000.342.16%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.